About Intervet India Private Limited
Data last updated:
Intervet India Private Limited is a private limited company based in Pune, Maharashtra, India, a subsidiary of Intervet Holding B.V.. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 15 May 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U52311MH1996PTC099536. Its GSTIN is 27AAACH1671F1ZU (Maharashtra). The company holds 16 GST registrations, of which 12 are active.
The company has an authorised share capital of ₹17.5 Cr and a paid-up capital of ₹17 Cr. It is led by directors including Yash Goyal (Managing Director) and Rupesh Navinchandra Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6th Floor Tower 5 World Trade Center Survey No 1 Kharadi, Pune, Maharashtra, India – 411014.
As per the financials filed for FY 2025, the company reported a revenue of ₹696.24 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹79.99 Cr (net margin 11.5%) and EBITDA of ₹112.17 Cr (EBITDA margin 16.1%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 15% over five years.
The company has about 274 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: MSD-Animal Health. As per MCA filings, the company has open charges of ₹7.57 Lakh and satisfied charges of ₹7.57 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website msd-animal-health.co.in.
Company details
Contact details
Intervet India Private Limited's registered office is in Pune, Maharashtra. Its website is msd-animal-health.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address6th Floor Tower 5 World Trade Center Survey No 1 Kharadi, Pune, Maharashtra, India – 411014
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Intervet India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Intervet India operates one associated brand: MSD-Animal Health. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Animal health products and services, including vaccines and pharmaceuticals, are provided in India. | msd-animal-health.co.in |
Business activity
The main business activities of Intervet India are trade and manufacturing. In detail, this covers wholesale trading and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Intervet India Private Limited, buy the company report.
Financials of Intervet India Private Limited
FY 2025 filings availableIntervet India Private Limited reported revenue of ₹696.24 Cr (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 14% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹112.17 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹79.99 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.1% | ||||
| Net Profit Margin | 11.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Intervet India Private Limited, buy the company report.
Board of directors of Intervet India Private Limited
Intervet India has 3 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupesh Navinchandra Shah Also directs: Allflex India Private Limited | Whole-Time Director | 27 Nov 2018 | 7 Years 10 Months | Current |
| Barry Lee Maccoy Jr | Director | 16 Jul 2019 | 7 Years 3 Months | Current |
| Yash Goyal Also directs: Allflex India Private Limited | Managing Director | 21 Jun 2012 | 14 Years 4 Months | Current |
Auditor
Intervet India Private Limited is audited by Price Waterhouse & Co Bangalore LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse & Co Bangalore LLP | FY 2022 | 007567S/S-200012 |
Shareholding
The shareholding of Intervet India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Intervet India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jun 2017 | 100115715 | Others | ₹7.57 Lakh | Satisfied |
To see the full charge records of Intervet India Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Intervet India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Intervet India Private Limited has 3 MSME Form 1 returns on record between 2019 and 2023, listing 24 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Cargomen Logistics India | |||
| Law First Consulting LLP | |||
| an individual supplier | |||
| Medibios Laboratories Limited |
To see the full MSME payment records of Intervet India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Intervet India Private Limited has a workforce of 274 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Intervet India has 16 GST registrations: 12 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACH1671F1ZU | Maharashtra | Active | 01 Jul 2017 |
| 27AAACH1671F2ZT | Maharashtra | Active | 30 Aug 2017 |
| 03AAACH1671F1Z4 | Punjab | Active | 01 Jul 2017 |
| 06AAACH1671F1ZY | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Intervet India Private Limited, buy the company report.
Recent activity
Intervet India Private Limited has 19 board changes on record since 2007: 3 appointments and 16 cessations. The latest: Barry Lee Maccoy Jr ceased to be Additional Director on 27 Sep 2019.
12 earlier events are in the company report.
Frequently asked questions
Intervet India is an active private limited company based in Pune, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 15 May 1996 (30+ years old) and is registered under CIN U52311MH1996PTC099536.
Intervet India has 3 current directors:
- Yash Goyal - Managing Director
- Rupesh Navinchandra Shah - Whole-Time Director
- Barry Lee Maccoy Jr - Director
The latest financial statements of Intervet India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Intervet India is 27AAACH1671F1ZU, registered in Maharashtra. The company has 16 GST registrations in all, of which 12 are active and 4 are cancelled or inactive. Other active GSTINs include 27AAACH1671F2ZT (Maharashtra), 03AAACH1671F1Z4 (Punjab), 06AAACH1671F1ZY (Haryana).
The CIN (Corporate Identification Number) of Intervet India is U52311MH1996PTC099536. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Intervet India was incorporated on 15 May 1996, making it 30+ years old. It is registered with the Registrar of Companies, Pune.
Barry Lee Maccoy Jr ceased to be Additional Director on 27 Sep 2019. Rupesh Navinchandra Shah ceased to be Director on 27 Sep 2019. Barry Lee Maccoy Jr was appointed as Director on 16 Jul 2019. Intervet India has 19 board changes on record in total.
Intervet India has 3 MSME Form 1 returns on record between 2019 and 2023, listing 24 overdue payments to 4 micro and small suppliers. The latest return was filed on 30 Aug 2023.
Intervet India can be reached through the website msd-animal-health.co.in. Its registered office is in Pune, Maharashtra, India.
The registered office of Intervet India is at 6th Floor Tower 5 World Trade Center Survey No 1 Kharadi, Pune, Maharashtra, India – 411014.
Intervet India operates in the pharma industry, in the animal pharmaceuticals and healthcare segment.